Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 5Phase 3 3Phase 2 2Phase 1/2 1

Status

Completed 21Not yet recruiting 4Recruiting 3Active not recruiting 3Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 285Prostatic Neoplasms 208Neoplasms 202Neoplasm Metastasis 179Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 157Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 104Carcinoma, Renal Cell 104Brain Neoplasms 89Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 84Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 59

Interventions

ioflupane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Disease × Clear all
NCT03185182 2019-06-21

RCCSCAN

Region Skane

Phase 2 Terminated
5 enrolled 5 charts
Genitourinary

Carcinoma, Renal Cell, Disease

NCT01898273 2015-09-09

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Cellectar Biosciences, Inc.

Phase 2 Terminated
7 enrolled
CNS

Disease, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡